Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127133381 | 12713338 | 1 | I | 20160825 | 20160902 | 20160902 | EXP | CA-BAXTER-2016BAX045338 | BAXTER | 21.00 | YR | M | Y | 0.00000 | 20160902 | OT | CA | CA |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127133381 | 12713338 | 1 | PS | FORANE | ISOFLURANE | 1 | Unknown | LIQUID INHALATION | U | 17624 | INHALATION VAPOUR, LIQUID | ||||||||
127133381 | 12713338 | 2 | SS | FORANE | ISOFLURANE | 1 | Parenteral | LIQUID INHALATION | U | 17624 | INHALATION VAPOUR, LIQUID | ||||||||
127133381 | 12713338 | 3 | SS | APO-levetiracetam | LEVETIRACETAM | 1 | Parenteral | U | 0 | TABLET | |||||||||
127133381 | 12713338 | 4 | SS | APO-levetiracetam | LEVETIRACETAM | 1 | Unknown | U | 0 | TABLET | |||||||||
127133381 | 12713338 | 5 | SS | APO-MIDAZOLAM | MIDAZOLAM HYDROCHLORIDE | 1 | Unknown | LIQUID INTRAMUSCULAR | U | 0 | |||||||||
127133381 | 12713338 | 6 | SS | APO-MIDAZOLAM | MIDAZOLAM HYDROCHLORIDE | 1 | Parenteral | LIQUID INTRAMUSCULAR | U | 0 | |||||||||
127133381 | 12713338 | 7 | SS | APO-valproic | VALPROIC ACID | 1 | Unknown | U | 0 | SYRUP | |||||||||
127133381 | 12713338 | 8 | SS | APO-valproic | VALPROIC ACID | 1 | Parenteral | U | 0 | SYRUP | |||||||||
127133381 | 12713338 | 9 | SS | PHENYTOIN. | PHENYTOIN | 1 | Parenteral | U | 0 | ||||||||||
127133381 | 12713338 | 10 | SS | PHENYTOIN. | PHENYTOIN | 1 | Unknown | U | 0 | ||||||||||
127133381 | 12713338 | 11 | SS | PROPOFOL. | PROPOFOL | 1 | Parenteral | EMULSION | U | 0 | INJECTION | ||||||||
127133381 | 12713338 | 12 | SS | PROPOFOL. | PROPOFOL | 1 | Unknown | EMULSION | U | 0 | INJECTION | ||||||||
127133381 | 12713338 | 13 | SS | VIMPAT | LACOSAMIDE | 1 | Unknown | U | 0 | ||||||||||
127133381 | 12713338 | 14 | SS | VIMPAT | LACOSAMIDE | 1 | Parenteral | U | 0 | ||||||||||
127133381 | 12713338 | 15 | C | immune globulin intravenous (human) | HUMAN IMMUNOGLOBULIN G | 1 | Unknown | SOLUTION INTRAVENOUS | 0 | ||||||||||
127133381 | 12713338 | 16 | C | METHYLPREDNISOLONE NOS | METHYLPREDNISOLONE OR METHYLPREDNISOLONE ACETATE | 1 | Unknown | 0 | |||||||||||
127133381 | 12713338 | 17 | C | PHENOBARBITAL. | PHENOBARBITAL | 1 | Unknown | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127133381 | 12713338 | 1 | Anaesthesia procedure |
127133381 | 12713338 | 3 | Status epilepticus |
127133381 | 12713338 | 5 | Status epilepticus |
127133381 | 12713338 | 7 | Status epilepticus |
127133381 | 12713338 | 9 | Status epilepticus |
127133381 | 12713338 | 11 | Status epilepticus |
127133381 | 12713338 | 13 | Status epilepticus |
127133381 | 12713338 | 15 | Product used for unknown indication |
127133381 | 12713338 | 16 | Product used for unknown indication |
127133381 | 12713338 | 17 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127133381 | 12713338 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127133381 | 12713338 | Brain oedema | |
127133381 | 12713338 | Clostridium difficile infection | |
127133381 | 12713338 | Diabetes insipidus | |
127133381 | 12713338 | Hypotension | |
127133381 | 12713338 | Intestinal ischaemia | |
127133381 | 12713338 | Superinfection | |
127133381 | 12713338 | Systemic inflammatory response syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |